Bioactive peptides are a class of biological molecules that are usually buried in the structure of the parent protein and only become active after the protein is cleaved. CD ComputaBio's team of experts is experienced and has participated in research projects at some scientific research institutions and universities, and has mastered a variety of advanced modeling technologies for bioactive peptides.
Bioactive peptides have different types of physiological activity, depending on their type, quantity, sequence, and the nature of their amino acids. In terms of treatment, peptides have many benefits that make them more useful than traditional drugs. For example, active peptides have more specific activity on target tissues, so they have little or no toxic effects; they are effective even at low concentrations. This feature is effective in treating chronic diseases. On the other hand, synthetic chemical compounds that are often used as drugs have cumulative effects on the body. While they are still active, these chemicals may cause environmental problems due to their excretion.
Fig 1. Schematic representation of various types of bioactive peptides from food proteins. (Fadimu G J, et al., 2022)
CD ComputaBio specializes in providing comprehensive bioactive peptides modeling services. CD ComputaBio leverages the latest advances in computational biology, computational chemistry, and structural biology to provide clients with insights into the structure, function and property predictions of bioactive peptides.
Integration with Machine Learning
Artificial intelligence and machine learning advances can enhance peptide modeling by identifying patterns and predicting bioactivity based on large data sets, further refining the design process.
Customization for Individual Needs
Bioactive peptide modeling can be tailored to meet different research purposes, including peptide modeling, kinetic simulations, stability analysis, etc.
Cost-Effectiveness
Computational modeling reduces the need for extensive experimental trials in the early stages of research. This approach can significantly reduce costs because fewer peptides need to be synthesized and tested in the lab.
CD ComputaBio is a professional service provider for the bioactive peptide modeling industry. CD ComputaBio provides customers with the most accurate modeling data and rich modeling methods. Our team of computational biology experts has excellent performance in bioactive peptide modeling method selection, model optimization, model evaluation, etc. If you are interested in our services or have any questions, please feel free to contact us.
Reference: